FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to nephrology, and can be used for treating patients suffering renal insufficiency and especially for treating acute renal insufficiency. Treatment and prevention of acute and chronic renal insufficiency are ensured by the administration of physiologically acceptable lithium salts in physiologic saline in concentration 10-100 mg/ml at lithium salts concentration 0.5-2 mmol/l in blood serum.
EFFECT: ensured treatment and prevention of acute and chronic renal insufficiency.
16 cl, 4 ex, 5 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| MODEL TEST SYSTEM FOR CHECKING EXPOSURE EFFICIENCY ON INFLAMMATORY PROCESS IN RENAL TISSUE | 2009 |
|
RU2425425C2 |
| PRODRUGS OF MULTIFUNCTIONAL NITROXIDE DERIVATIVES AND USES THEREOF | 2014 |
|
RU2659220C2 |
| USE OF PHARMACEUTICAL COMPOSITION CONTAINING CHOLINE ALFOSCERATE AND 2-ETHYL-6-METHYL-3-HYDROXYPYRIDINE SUCCINATE AS NEUROPROTECTIVE AGENT IN CEREBRAL ISCHEMIA | 2023 |
|
RU2819828C1 |
| APPLICATION OF VANADIUM COMPOUNDS FOR MAINTAINING NORMOGLYCEMIA IN MAMMALS | 2012 |
|
RU2624495C2 |
| USE OF NICOTINE, ITS ANALOGUES, PREDECESSORS AND SUCCESSORS TO TREAT DIFFERENT PATOLOGIC PROCESSES RESPONDING TO TREATMENT BY INTRODUCTION OF α-MSH FOR PREVENTION OR TREATMENT PURPOSES | 2006 |
|
RU2442584C2 |
| METHOD FOR PREDICTION OF NEPHROSCLEROSIS IN CHILDREN WITH CHRONIC PYELONEPHRITIS | 2018 |
|
RU2689790C1 |
| METHOD FOR MODELING PYELONEPHRITIS | 1999 |
|
RU2149463C1 |
| METHOD FOR CORRECTION OF LIPID PEROXIDATION PROCESSES IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION | 2016 |
|
RU2627458C1 |
| METHOD FOR PREPARING LITHIUM SALT OF COMENIC ACID AND USING IT AS ANTIOXIDANT, STRESS- AND NEUROPROTECTIVE AGENT | 2011 |
|
RU2477722C1 |
| METHOD OF AGENT APPLICATION BASED ON HUMAN MODIFIED PEROXYREDOXIN 2 FOR CORRECTING CONSEQUENCES OF ISCHEMIC-REPERFUSIVE KIDNEY DAMAGE | 2020 |
|
RU2747121C1 |
